|
Gene: OSER1-AS1 |
Gene summary for OSER1-AS1 |
Gene summary. |
Gene information | Species | Human | Gene symbol | OSER1-AS1 | Gene ID | 100505783 |
Gene name | OSER1 divergent transcript | |
Gene Alias | OSER1-AS1 | |
Cytomap | 20q13.12 | |
Gene Type | ncRNA | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
100505783 | OSER1-AS1 | P1T-E | Human | Esophagus | ESCC | 1.98e-11 | 4.38e-01 | 0.0875 |
100505783 | OSER1-AS1 | P2T-E | Human | Esophagus | ESCC | 4.67e-11 | 1.89e-01 | 0.1177 |
100505783 | OSER1-AS1 | P4T-E | Human | Esophagus | ESCC | 2.20e-02 | 9.02e-02 | 0.1323 |
100505783 | OSER1-AS1 | P8T-E | Human | Esophagus | ESCC | 6.52e-12 | 2.28e-01 | 0.0889 |
100505783 | OSER1-AS1 | P9T-E | Human | Esophagus | ESCC | 3.05e-03 | 9.65e-02 | 0.1131 |
100505783 | OSER1-AS1 | P10T-E | Human | Esophagus | ESCC | 4.49e-19 | 3.86e-01 | 0.116 |
100505783 | OSER1-AS1 | P11T-E | Human | Esophagus | ESCC | 2.46e-02 | 1.37e-01 | 0.1426 |
100505783 | OSER1-AS1 | P12T-E | Human | Esophagus | ESCC | 6.64e-15 | 2.68e-01 | 0.1122 |
100505783 | OSER1-AS1 | P15T-E | Human | Esophagus | ESCC | 4.72e-09 | 1.78e-01 | 0.1149 |
100505783 | OSER1-AS1 | P16T-E | Human | Esophagus | ESCC | 7.41e-18 | 3.03e-01 | 0.1153 |
100505783 | OSER1-AS1 | P17T-E | Human | Esophagus | ESCC | 1.49e-02 | 1.32e-01 | 0.1278 |
100505783 | OSER1-AS1 | P19T-E | Human | Esophagus | ESCC | 7.48e-03 | 3.20e-01 | 0.1662 |
100505783 | OSER1-AS1 | P20T-E | Human | Esophagus | ESCC | 8.62e-07 | 1.71e-01 | 0.1124 |
100505783 | OSER1-AS1 | P21T-E | Human | Esophagus | ESCC | 2.09e-08 | 2.35e-01 | 0.1617 |
100505783 | OSER1-AS1 | P22T-E | Human | Esophagus | ESCC | 8.40e-11 | 2.32e-01 | 0.1236 |
100505783 | OSER1-AS1 | P23T-E | Human | Esophagus | ESCC | 2.13e-09 | 1.96e-01 | 0.108 |
100505783 | OSER1-AS1 | P24T-E | Human | Esophagus | ESCC | 5.05e-14 | 8.40e-02 | 0.1287 |
100505783 | OSER1-AS1 | P26T-E | Human | Esophagus | ESCC | 1.20e-17 | 3.40e-01 | 0.1276 |
100505783 | OSER1-AS1 | P27T-E | Human | Esophagus | ESCC | 8.22e-10 | 1.37e-01 | 0.1055 |
100505783 | OSER1-AS1 | P28T-E | Human | Esophagus | ESCC | 1.83e-08 | 5.45e-02 | 0.1149 |
Page: 1 2 3 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Stomach | WIM | |
Stomach | SIM | |
Liver | NAFLD | |
Liver | Cirrhotic | |
Liver | HCC |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |